The global healthcare market has experienced significant changes in the past several years. Rising consumption of healthcare goods and services has led to rapidly increasing costs in both private and public markets which in turn has increased the influence of non-physicians in treatment decisions. We explore this issue and a novel solution for addressing it within the commercialization process.